<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AJPS</journal-id><journal-title-group><journal-title>American Journal of Plant Sciences</journal-title></journal-title-group><issn pub-type="epub">2158-2742</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ajps.2016.711145</article-id><article-id pub-id-type="publisher-id">AJPS-69634</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Toxicity and Antiviral Activities of Some Medicinal Plants Used by Traditional Medical Practitioners in Zimbabwe
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Deniz</surname><given-names>Iklim Viol</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lameck</surname><given-names>Shoriwa Chagonda</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sylvester</surname><given-names>Rodgers Moyo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ali</surname><given-names>Hikmet Mericli</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Pharmacognosy, School of Pharmacy, University of Istanbul, Istanbul, Turkey</addr-line></aff><aff id="aff2"><addr-line>Faculty of Health and Applied Sciences, Namibia University of Science and Technology, Windhoek, Namibia</addr-line></aff><aff id="aff1"><addr-line>School of Pharmacy, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>08</month><year>2016</year></pub-date><volume>07</volume><issue>11</issue><fpage>1538</fpage><lpage>1544</lpage><history><date date-type="received"><day>24</day>	<month>June</month>	<year>2016</year></date><date date-type="rev-recd"><day>accepted</day>	<month>7</month>	<year>August</year>	</date><date date-type="accepted"><day>10</day>	<month>August</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Genital herpes, usually caused by Herpes Simplex Virus type-2 (HSV-2), is the commonest sexually transmitted disease especially amongst rural women in Southern Africa including Zimbabwe. This predisposes them to HIV/AIDS infection, cancer and opportunistic infections (OIs). Current antiviral treatments are often cytotoxic and/or ineffective. This motivates active research to find alternative safer drugs or lead drugs from traditional medicinal sources. Twenty six (26) methanol extracts from commonly used and often endangered plant species (14) used by communities and traditional medical practitioners for treating illnesses and sexually transmitted diseases from 5-selected districts of Zimbabwe were investigated for toxicity by Brine shrimp lethality test (BSLT) and by 50% Cytopathic effect on VERO cultured cells. The extracts were also tested for antiviral activity against Herpes Simplex Virus-2 (HSV-2) by the End Point Titration Technique (EPTT) and Neutralisation Test (NT) on VERO cells. Results from the BSLTs ranged
   
  66.66 - 4304 μg/ml; 50% Cytopathic effect from 19.53 - 312 μg/ml whilst the NT ID
  <sub>50</sub>
   values ranged from 10.41 - 125 μg/ml. The antiviral EPTT reduction factor (RF) was
   
  1 - 10
  <sup>4</sup>
   with 13 extracts showing RF ≥ 10
  <sup>3</sup>
  . All the plant extracts had moderate to high toxicity (LC
  <sub>50</sub>
  , 789 - 66 μg/ml) in the BSLT. Six extracts had LC
  <sub>50</sub>
   values greater than 1000 μg/ml. All 26 extracts were cytotoxic with CC
  <sub>50</sub>
   values &lt; 500 ug/ml of which 19 were more toxic CC
  <sub>50</sub>
   &lt; 100 ug/ml. Nine extracts had 
  in vitro 
  therapeutic indexes ≥ 3.7. 
  Cassia abbreviata
  , 
  Dichrostachys cinerea
   and 
  Hypoxis hemerocallidea
   had therapeutic indexes (TI) 7.5 - 15.0. The more active plant extracts were from roots and root tubers. The results confirm the rationale for the use of traditional medicinal plants by traditional medical practitioners for treating various diseases and could bring awareness for their better use and improve conservation. The results also provide an opportunity to develop more efficacious drugs by isolating lead compounds and determining their mode of action.
 
</p></abstract><kwd-group><kwd>Medicinal Plants</kwd><kwd> Toxicity</kwd><kwd> Antiviral Activity</kwd><kwd> Herpes Simplex Virus-2</kwd><kwd> Zimbabwe</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Third world countries are often endowed with rich flora and fauna which are put to good use in their traditional medical practices. Zimbabwe has over 5000 plant species of which 500 are established in Traditional Medicine (TM) since being legalised in 1981 through an Act of Parliament [<xref ref-type="bibr" rid="scirp.69634-ref1">1</xref>] . Traditional Medical Practitioners (TMPs) treat common illnesses and chronic diseases with claims to treat HIV/AIDS and opportunistic infections (OIs); this is not uncommon in Africa as a whole. Medicinal plants (MPs) still play a central role as sources of drugs for drug development into modern medicines and are still the mainstay for TMPs and for Complementary and Alternative Medicines (CAM) [<xref ref-type="bibr" rid="scirp.69634-ref2">2</xref>] - [<xref ref-type="bibr" rid="scirp.69634-ref4">4</xref>] . The combined effect of poverty and unemployment, civil unrest, land hunger and disease prevalence in developing countries has pushed more and more people towards the traditional medical practice. With over 55,000 registered TMPs in Zimbabwe alone, the protection of the 500 medicinal plants identified as playing a significant role in the traditional practice becomes a problem for conservationists [<xref ref-type="bibr" rid="scirp.69634-ref1">1</xref>] . The ever increasing demand for more land for agriculture and land reforms, human settlements, urban and industrial expansion has put many African governments on the back foot as they seek to address these challenges. Governments are therefore challenged to add value to MPs through research to achieve the multiple goals of conversation awareness and health improvement for the poor. Through technical initiatives, protocols, and/or encouragements, research into traditional medicine and medicinal plants is being pursued vigorously [<xref ref-type="bibr" rid="scirp.69634-ref5">5</xref>] . In Zimbabwe, a study was set up with the help of GEF/UNDP/MET (Ministry of Environment and Tourism) to carry out scientific laboratory studies on 50 extracts from 26 medicinal plants commonly used by communities to assess their conservation status in five selected districts from two regions of the country and to raise awareness of their importance and promote their sustainable use. Subsequently, we reported the antioxidant properties of extracts from these plant species [<xref ref-type="bibr" rid="scirp.69634-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.69634-ref7">7</xref>] as well as their antimicrobial and phytochemical properties [<xref ref-type="bibr" rid="scirp.69634-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.69634-ref9">9</xref>] . The laboratory studies confirmed the rationale for their use in traditional medical practice in line with other studies elsewhere to evaluate TMs targeted at finding alternative safer drugs to treat modern illnesses and to overcome growing resistance to infective agents. Our continuing research is now focused on selective studies and value addition through identifying active principles and action mechanisms [<xref ref-type="bibr" rid="scirp.69634-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.69634-ref11">11</xref>] . The HIV/AIDS virus still remain a threat to mankind and the current report presents the toxicity and antiviral properties of 14 plant species used in traditional medical practice which could have a bearing on the development of potential antiviral and anticancer drugs. This report highlights some of the key findings of the preliminary laboratory studies on toxicity and antiviral activities in the pilot study [<xref ref-type="bibr" rid="scirp.69634-ref12">12</xref>] .</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Ethnobotanical Surveys and Plant Materials</title><p>Ethno-botanical surveys on traditional medicinal plants used for treating common ailments, those most traded and threatened were carried out in five districts: Bulilima, Chimanimani, Chipinge, Mangwe and Matobo and the plants identified and authenticated by the National Herbarium and Botanic Gardens, Harare, as previously reported [<xref ref-type="bibr" rid="scirp.69634-ref8">8</xref>] . The plant materials roots, leaves, twigs, tuber, bark or whole, were dried, finely ground and stored.</p></sec><sec id="s2_2"><title>2.2. Preparation of Extracts for Bioactive Tests</title><p>Selected plant parts were powdered (30 g), macerated in methanol (200 ml) [<xref ref-type="bibr" rid="scirp.69634-ref13">13</xref>] , filtered and the filtrate evaporated off under reduced pressure, freeze dried and stored at −20˚C. Part of the lyophilised extracts were dissolved in DMSO (10 mg/ml), filtered under aseptic conditions and stored for further bioactive use at −20˚C.</p></sec><sec id="s2_3"><title>2.3. Brine Shrimp Bioactivity Testing</title><p>Bioactivity testing using the Brine Shrimp (Artemia salina) Lethality Test (BSLT) method was carried out in triplicate with different concentrations of the sterilized plant extracts in brine solution (10 &#181;g/ml - 1000 &#181;g/ml) and the percentage lethality of the nauplii determined [<xref ref-type="bibr" rid="scirp.69634-ref14">14</xref>] . The concentration of the extract that kills 50% of the shrimps, “Lethal Concentration<sub>50</sub>” (LC<sub>50</sub>) values were recorded using Nerium oleander as the positive control by GraphPad Prism 5.0 linear regression and Pearson’s two tailed analysis for 95% confidence limits (95% CI) [<xref ref-type="bibr" rid="scirp.69634-ref15">15</xref>] .</p></sec><sec id="s2_4"><title>2.4. Cytotoxicity and Antiviral Activity of the Plant Extracts</title><p>The lyophilized methanol extracts were dissolved in DMSO to a concentration of 10 mg/ml. Vero cells (African green monkey kidney) (Highveld Ltd., South Africa) were grown and maintained in essential growth medium supplemented with 5% foetal calf serum and incubated under 5% carbon dioxide at 37˚C. The confluent cells were removed and trypsinated with phosphate buffered saline solution to achieve a cell concentration of 1 - 2 &#215; 10<sup>4</sup> cells per well for VERO cells.</p><p>Herpes simplex virus 2 (HSV-2) (Highveld Ltd., South Africa) was propagated on Vero cells and the recovered virus suspension (1 ml) diluted by infecting Vero confluent monolayers grown on microtitre plates with 0.1 ml of serial tenfold dilutions of the virus suspension quadruplicated and observed for 7 days for cytopathic effect (CPE). The HSV-2 virus titre was obtained from the 50% tissue culture infections dose per ml (TCID<sub>50/ml</sub>) [<xref ref-type="bibr" rid="scirp.69634-ref16">16</xref>] .</p><p>Cytotoxicity of the different plant extracts that could cause non-specific cytopathic effect (CPE) on confluent Vero cells in growth medium was determined by using 100 ml of serial two fold dilution of the plant extracts onto confluent Vero cells on microtitre plates in quadruplicate. The 50% cytotoxicity concentration (CC<sub>50</sub>) was defined as the plant extract concentration causing 50% CPE compared to uninfected cells [<xref ref-type="bibr" rid="scirp.69634-ref16">16</xref>] . The maximum nontoxic dilution (MNTD) was taken as the next dilution after the TCID<sub>50</sub> of the plant extract and used for the antiviral assays.</p></sec><sec id="s2_5"><title>2.5. Antiviral Assays</title><p>Antiviral assays were carried out using the Neutralization test (NT) to determine non-cytotoxic concentration (ID<sub>50</sub>) that inhibits/protects 50% of the monolayer cells against destruction by the virus compared to uninfected cells using the Spearman-Karber formula [<xref ref-type="bibr" rid="scirp.69634-ref17">17</xref>] and by the End point titration technique (EPTT) [<xref ref-type="bibr" rid="scirp.69634-ref18">18</xref>] . In the EPPT assay, confluent monolayer Vero cells were grown on 96-well microtitre plates with the medium removed from the wells. 0.05 ml (MNTD) of the plant extract and 0.05 ml of growth maintenance medium followed 1 h later by 0.05 ml of tenfold HSV-2 serial diluted virus suspension and the mixture incubated at 37˚C. Controls consisted of Vero cells infected with virus and not treated with plant extract and virus uninfected and untreated cells. All tests were compared with a positive control, acyclor (Sigma). The antiviral activity was determined as the reduction factor (RF) of the viral titre: the ratio of virus titre in the absence and presence of the plant extract. A promising antiviral has a RF ≥ 10<sup>3</sup> [<xref ref-type="bibr" rid="scirp.69634-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.69634-ref18">18</xref>] .</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Brine Shrimp Bioactivity Testing</title><p>The bioactivity of the plant extracts using the Brine shrimp lethality test (BSLT) indicated that plants in this category were relatively toxic with 15 of the 26 extracts recording LC<sub>50</sub> &lt; 500 &#181;g/ml (<xref ref-type="table" rid="table1">Table 1</xref>). Only 6 extracts had LC<sub>50</sub> &gt; 1000 &#181;g/ml. Potentially very toxic plants were T. sericea (LC<sub>50</sub> = 66.7 &#181;g/ml) and K. africana (LC<sub>50</sub> = 117.4 &#181;g/ml) showing greater toxicity than the positive control N. oleander (LC<sub>50</sub> = 141.7 &#181;g/ml). The BSLT bioassay is widely used as a basic screening test for toxicity in prospecting for suspected biological activity in crude and isolated plant extracts from traditional folklore [<xref ref-type="bibr" rid="scirp.69634-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.69634-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.69634-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.69634-ref19">19</xref>] - [<xref ref-type="bibr" rid="scirp.69634-ref22">22</xref>] .</p></sec><sec id="s3_2"><title>3.2. Cytotoxicity and Antiviral Activity</title><p>Cytotoxicity effects for the extracts on Vero cells showed all 26 extracts had CC<sub>50</sub> &lt; 500 ug/ml, 19 with CC<sub>50</sub> &lt; 100 ug/ml and 12 with CC<sub>50</sub> &lt; 50 ug/ml (<xref ref-type="table" rid="table1">Table 1</xref>) indicating potential antitumour and/or antiviral activity. Antiviral screening tests indicated some plant extracts possess potential activities to protect the cells against HSV-2</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Plants chosen for toxicity and antiviral tests</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >No</th><th align="center" valign="middle" >Species, family name, voucher number, status</th><th align="center" valign="middle" >Plant part</th><th align="center" valign="middle" >BSLT LC<sub>50 </sub> (ug/ml)</th><th align="center" valign="middle" >CC<sub>50</sub> (50% CPE) (ug/ml)</th><th align="center" valign="middle" >NT-ID<sub>50 </sub> (ug/ml)</th><th align="center" valign="middle" >TI: CC<sub>50</sub>/ID<sub>50</sub></th><th align="center" valign="middle" >EPTT (RF<sup>b</sup>)</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Cassia abbreviate Oliv., Fabaceae (2721): Cm. Status: Cm</td><td align="center" valign="middle" >lf rt bk</td><td align="center" valign="middle" >454.93 &#177; 18.60 445.72 &#177; 22.15 1319.37 &#177; 356.63</td><td align="center" valign="middle" >156.25 156.25 39.06</td><td align="center" valign="middle" >20.83 10.41 NA</td><td align="center" valign="middle" >7.5 15.0 -</td><td align="center" valign="middle" >10<sup>2</sup> 10<sup>3</sup> 1</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Dichrostachys cinerea (L.) Wight and Arn. Mimosaceae (32): Cm.</td><td align="center" valign="middle" >lf rt</td><td align="center" valign="middle" >539.39 &#177; 78.24 4304.59 &#177; 685.69</td><td align="center" valign="middle" >78.13 312.50</td><td align="center" valign="middle" >10.41 83.33</td><td align="center" valign="middle" >7.5 3.7</td><td align="center" valign="middle" >10<sup>4</sup> 10<sup>2</sup></td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Elaedendron matabelicum (Loes). Steedman Celastraceae (2121): Th., Endemic</td><td align="center" valign="middle" >rt</td><td align="center" valign="middle" >1012.31 &#177; 217.69</td><td align="center" valign="middle" >78.13</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >Elephantorrhiza goetzei Harms. Fabaceae (7136): Th.</td><td align="center" valign="middle" >rt</td><td align="center" valign="middle" >356.55 &#177; 24.55</td><td align="center" valign="middle" >156.25</td><td align="center" valign="middle" >83.33</td><td align="center" valign="middle" >1.9</td><td align="center" valign="middle" >10<sup>2</sup></td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >Flacourtia indica (Burm. f.) Merr. Flacourticaceae (57/62): Th.</td><td align="center" valign="middle" >lf rt</td><td align="center" valign="middle" >281.81 &#177; 26.14 467.31 &#177; 39.01</td><td align="center" valign="middle" >78.13 156.25</td><td align="center" valign="middle" >83.33 125.00</td><td align="center" valign="middle" >0.9 1.3</td><td align="center" valign="middle" >10<sup>2</sup> 10<sup>3</sup></td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >Gymnosporia senegalensis (Lam.) Loes. Celastraceae (15): Cm.</td><td align="center" valign="middle" >lf rt tw</td><td align="center" valign="middle" >789.37 &#177; 104.06 2185.61 &#177; 872.25 754.70 &#177; 182.57</td><td align="center" valign="middle" >39.06 78.13 19.53</td><td align="center" valign="middle" >10.41 20.83 15.63</td><td align="center" valign="middle" >3.8 3.8 1.2</td><td align="center" valign="middle" >10<sup>3</sup> 10<sup>3</sup> 10<sup>3</sup></td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >Hypoxis hemerocallidea Fisch. &amp; Ave’-Lall. Hypoxidaceae (MTDV06): Th.</td><td align="center" valign="middle" >tb</td><td align="center" valign="middle" >735.34 &#177; 89.39</td><td align="center" valign="middle" >156.25</td><td align="center" valign="middle" >10.41</td><td align="center" valign="middle" >15.0</td><td align="center" valign="middle" >10<sup>3</sup></td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >Khaya anthotheca (Welw.) DC. Meliaceae (892): Cm.</td><td align="center" valign="middle" >bk</td><td align="center" valign="middle" >482.19 &#177; 43.49</td><td align="center" valign="middle" >39.06</td><td align="center" valign="middle" >31.25</td><td align="center" valign="middle" >1.2</td><td align="center" valign="middle" >10<sup>2</sup></td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >Kigelia africana (Lam.) Benth. Bignoniaceae (5990): Cm.</td><td align="center" valign="middle" >bk ft rt</td><td align="center" valign="middle" >262.20 &#177; 25.07 117.41 &#177; 30.27 501.35 &#177; 34.88</td><td align="center" valign="middle" >39.06 39.06 39.06</td><td align="center" valign="middle" >31.25 31.25 NA</td><td align="center" valign="middle" >1.2 1.2 -</td><td align="center" valign="middle" >10<sup>3</sup> 10<sup>4</sup> 1</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >Rhuschirindensis Baker f. Anacardiaceae (103/67): Cm.</td><td align="center" valign="middle" >lf rt</td><td align="center" valign="middle" >1023.26 &#177; 161.69 316.60 &#177; 30.07</td><td align="center" valign="middle" >312.50 78.13</td><td align="center" valign="middle" >NA 20.83</td><td align="center" valign="middle" >- 3.8</td><td align="center" valign="middle" >1 10<sup>2</sup></td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >Sclerocarya birrea (A. Riich.) Hochst. Anacardiaceae (3114): Th, Cm.</td><td align="center" valign="middle" >bk</td><td align="center" valign="middle" >1112.37 &#177; 210.04</td><td align="center" valign="middle" >39.06</td><td align="center" valign="middle" >20.83</td><td align="center" valign="middle" >1.9</td><td align="center" valign="middle" >10<sup>3</sup></td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >Securidaca longepedunculata Fresen. Polygalaceae (264/59): V Th.</td><td align="center" valign="middle" >rt</td><td align="center" valign="middle" >351.89 &#177; 35.70</td><td align="center" valign="middle" >78.13</td><td align="center" valign="middle" >20.83</td><td align="center" valign="middle" >3.8</td><td align="center" valign="middle" >10<sup>3</sup></td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >Terminalia sericea Burch. Ex. DC. Combretaceae (5): Th., endemic</td><td align="center" valign="middle" >lf rt</td><td align="center" valign="middle" >66.66 &#177; 49.31 295.33 &#177; 37.19</td><td align="center" valign="middle" >39.06 39.06</td><td align="center" valign="middle" >31.25 20.83</td><td align="center" valign="middle" >1.2 1.9</td><td align="center" valign="middle" >10<sup>2</sup> 10<sup>3</sup></td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >Warburgia salutaris (Bertol.f.) Chiov. Canellaceae (CPDV06): V Th.</td><td align="center" valign="middle" >lf rt bk</td><td align="center" valign="middle" >351.41 &#177; 29.58 426.10 &#177; 55.55 359.66 &#177; 14.33</td><td align="center" valign="middle" >78.13 39.06 19.53</td><td align="center" valign="middle" >NA 31.25 NA</td><td align="center" valign="middle" >- 1.2 -</td><td align="center" valign="middle" >1 10<sup>3</sup> 1</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >Nerium oleander (ref-positive control)</td><td align="center" valign="middle" >lf</td><td align="center" valign="middle" >141.67 &#177; 68.15</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Acylor-1.50</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>Plant part investigated: lf = leaf; rt = root; tb = tuber; bk = bark; Environmental status S: Cm = common; Th = threatened; VTh = very threatened; BSLT, Brine shrimp lethality test LC<sub>50</sub>, lethal concentration that kills 50% of the shrimps with corresponding 95% confidence intervals (95% CI); CC<sub>50</sub> (50% CPE), plant extract cytotoxicity concentration that kills 50% tissue cells; NT, neutralisation test: NA = no activity; ID<sub>50</sub>, non-cytotoxic concentration that inhibits/protects 50% uninfected cells, NA = no activity; TI: therapeutic index = CC<sub>50</sub>/ID<sub>50</sub> EPPT, End point titration test. RF<sup>b</sup> antiviral reduction factor: ratio of viral titre of control in absence of extract over viral titre in presence of extract.</p><p>induced destruction with EPTT reduction factors (RFs) ≥ 10<sup>3</sup> (<xref ref-type="table" rid="table1">Table 1</xref>). D. cinerea (RF = 10<sup>4</sup>) and K. Africana (RF = 10<sup>4</sup>) were particularly active, however, most plants in the group had RFs ≥ 10<sup>3</sup> which activities were also mirrored in the neutralization test (NT) ID<sub>50</sub>s where acyclovir the positive control had ID<sub>50</sub> = 1.5. G. senegalensis, T. sericea and W. salutaris previously noted for their high antimicrobial activities [<xref ref-type="bibr" rid="scirp.69634-ref8">8</xref>] were also in the group of potential antiviral plants with high cytotoxicities (CC<sub>50</sub> &lt; 50 &#181;g/ml) and high reduction factors (RF = 10<sup>3</sup>) for some of their extracts. However, in addition to having a high reduction factor, a plant extract should also have a high therapeutic index (TI)/high sensitivity value in order to prevent cell destruction and be considered for further potential antiviral investigation. From this group (<xref ref-type="table" rid="table1">Table 1</xref>), Cassia abbreviata had TI values of 7 and 15 for leaf and root extract respectively, Dichrostachys cinerea TI = 7.5 for leaf extract and Hypoxis rooperi had TI = 15 for the tuber. Kigelia fruit showed a high reduction factor 10<sup>4</sup> but low therapeutic efficacy 1.2 in line with other reports where its anti-tumour and other biological properties are highlighted [<xref ref-type="bibr" rid="scirp.69634-ref21">21</xref>] - [<xref ref-type="bibr" rid="scirp.69634-ref28">28</xref>] . Plant extracts Gymnosporia senegalensis (Celastraceae), Warburgia salutaris (Canellaceae) and Terminalia sericea (Combretaceae) are popular plants in traditional practice. Recent studies are focusing on the toxicity, antiviral and antitumor properties of crude and isolates against different viral species especially HIV-1, HSV-1, HSV-2, anti- Dengue [<xref ref-type="bibr" rid="scirp.69634-ref29">29</xref>] - [<xref ref-type="bibr" rid="scirp.69634-ref38">38</xref>] . In general, all the plants in this study displayed both antiinfective and toxic properties (<xref ref-type="table" rid="table1">Table 1</xref>) whilst reports from phytochemical studies reflect flavonoids and condensed tannins largely responsible for the observed antiviral and anticancer activities [<xref ref-type="bibr" rid="scirp.69634-ref25">25</xref>] - [<xref ref-type="bibr" rid="scirp.69634-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.69634-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.69634-ref39">39</xref>] . Isolated fractions and derivatives can have greater toxicity and/or activity than the crude extracts, the case of artemisinin from Artemisia annua in the treatment of malaria [<xref ref-type="bibr" rid="scirp.69634-ref39">39</xref>] and the isolated phytoconstituents from Kigelia and Hypoxis species [<xref ref-type="bibr" rid="scirp.69634-ref24">24</xref>] - [<xref ref-type="bibr" rid="scirp.69634-ref27">27</xref>] .</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>Sub-Saharan Africa still suffers the great burden for HIV/AIDS with millions infected and affected. Though prevalence has fallen, availability of antiviral drugs poses a continuing challenge. The use of TMPs is often plagued with issues of safety and/or toxicity. The antimicrobial and antiviral activities demonstrated by the plant extracts are further proof to support claims by TPs of their ability to treat more serious illness including HIV/ AIDS and opportunistic infections [<xref ref-type="bibr" rid="scirp.69634-ref5">5</xref>] . Studies carried out from cited literature on traditional medicinal plants elsewhere have also demonstrated their potential antimicrobial and antiviral activities. Whilst the laboratory studies and biological results confirm traditional folkloric uses, their application in modern medicine has enormous challenges with respect to the standardisation of crude extracts, isolation and characterisation of key active principles and the adoption of clinical protocols gave the wide range of related plant species in different countries. This may not be helped by the lack of sponsorship for such research gave the poor state of the economies of most developing countries. In some cases, the active principles and their derivatives have proven more active than their crude extracts: artemisinin and derivatives (from Chinese Artemisia annua) [<xref ref-type="bibr" rid="scirp.69634-ref39">39</xref>] in the treatment of malaria; sitosterols, hypoxoside and rooperol (from African Hypoxis spp.) in the treatment of prostate cancer [<xref ref-type="bibr" rid="scirp.69634-ref25">25</xref>] . Likewise extracts from D. cinerea and C. abbreviata (Fabaceae), Kigelia africana (Bignoniaceae) and T. sericea (Combretaceae) should be studied for active principles, derivatives and followed by pre-clinical trials possible due to the wide spectrum of activities for isolates. The wide geographical variables make this some task but regions can adopt standards consistent with their findings from the wild where they are endemic or from propagation efforts where these are applicable. Our studies focused on local plants and reported wide scientific data which should attract more research. Such increased research activity has the potential to promote traditional medical practice by value addition to the medicinal plants used to treat patients, improve quality standards and the formulation of traditional remedies, bring awareness to the environmental status of TMPs and create opportunities for further development of TMPs into modern medicines.</p></sec><sec id="s5"><title>Acknowledgements</title><p>The authors would like to thank GEF/UNDP through the Ministry of Environment and Tourism (MET) for supporting two postgraduate students on the project, the local communities and traditional practitioners from the districts involved, the School of Pharmacy and the Research Board of the University of Zimbabwe and other national institutions for making this work possible through many linkages and collaborations.</p></sec><sec id="s6"><title>Cite this paper</title><p>Deniz Iklim Viol,Lameck Shoriwa Chagonda,Sylvester Rodgers Moyo,Ali Hikmet Mericli, (2016) Toxicity and Antiviral Activities of Some Medicinal Plants Used by Traditional Medical Practitioners in Zimbabwe. American Journal of Plant Sciences,07,1538-1544. doi: 10.4236/ajps.2016.711145</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.69634-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Chavunduka, G.L. (1997) Traditional Medicine in Modern Zimbabwe, Harare. University of Zimbabwe Publications, Harare.</mixed-citation></ref><ref id="scirp.69634-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Breyer-Brandwijk, M.G. and Watt, J.M. (1962) The Medicinal and Poisonous Plants of Southern and Eastern Africa. 2nd Edition, E. and S. Livingstone Ltd., Edinburgh.</mixed-citation></ref><ref id="scirp.69634-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Gelfand, M., Mavi, M., Drummond, R.B. and Ndemera, N. (1998) Traditional Medical Practitioners in Zimbabwe. Mambo Press, Gweru.</mixed-citation></ref><ref id="scirp.69634-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Hostettmann, K., Marston, A., Ndjoko, K. and Wolfender, J.L. (2000) The Potential of African Plants as a Source of Drugs. Current Organic Chemistry, 4, 973-1010. http://dx.doi.org/10.2174/1385272003375923</mixed-citation></ref><ref id="scirp.69634-ref5"><label>5</label><mixed-citation publication-type="book" xlink:type="simple">Mumba, E.M., Ed. (2007) Introduction to the NEPAD/Southern African Network for Biosciences. Proceedings of the First NEPAD/SANBIO Workshop on Scientific Validation of Traditional Medicine for Affordable Treatments of HIV/AIDS and Opportunistic Infections, Lusaka, 15-16 March 2007, 9-11.</mixed-citation></ref><ref id="scirp.69634-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Munodawafa, T., Chagonda, L.S., Viol, I., Muchuweti, M. and Moyo, R.S. (2010) Total Phenolic Content and Antioxidant Activity of Some Zimbabwean Traditional Medicinal Plants. Recent Progress in Medicinal Plants, Drug Plants III, 29, 364-373.</mixed-citation></ref><ref id="scirp.69634-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Viol, D.I., Chagonda, L.S., Munodawafa, T., Muchuweti, M.M., Moyo, S.R. and Mericli, A.H. (2013) Antioxidant Activity and Total Phenolic Contents of some Traditional Medicinal Plants from Zimbabwe. Journal of Biologically Active Products from Nature, 3, 345-352. http://dx.doi.org/10.1080/22311866.2013.782753</mixed-citation></ref><ref id="scirp.69634-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Viol, D.I., Chagonda, L.S., Moyo, S.R. and Mericli, A.H. (2013) Antibacterial, Antifungal and Phytochemical Activities of Some Medicinal Plants from Zimbabwe. Journal of Biologically Active Products from Nature, 3, 273-284.  
http://dx.doi.org/10.1080/22311866.2013.782758</mixed-citation></ref><ref id="scirp.69634-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Munodawafa, T., Chagonda, L.S. and Moyo, S.R. (2013) Antimicrobial and Phytochemical Screening of Some Zimbabwean Medicinal Plants. Journal of Biologically Active Products from Nature, 3, 323-330.  
http://dx.doi.org/10.1080/22311866.2013.782759</mixed-citation></ref><ref id="scirp.69634-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Munodawafa, T., Tagwireyi, D., Gadaga, L., Gomo, E., Bierman, F. and Chagonda, L.S. (2015) Acute and Subacute Oral Toxicity of Hydroethanolic Root Extract of Annona stenophyla Engl. and Diels in Sprague Dawley Rats. Journal of Biologically Active Products from Nature, 5, 349-356. http://dx.doi.org/10.1080/22311866.2015.1110501</mixed-citation></ref><ref id="scirp.69634-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Taderera, T., Chagonda, L.S., Gomo, E. and Shai, L.J. (2015) Inhibitory Activity of α-Glucosidase and α-Amylase by Annona stenophyllaroot Extract as Mechanism for Hypoglycaemic Control of DM. International Journal of Pharmacy, Photon, 106, 436-444.</mixed-citation></ref><ref id="scirp.69634-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Viol, D.I. (2013) Screening of Traditional Medicinal Plants from Zimbabwe for Phytochemistry, Antioxidant, Antimicrobial, Antiviral and Toxicological Activities. http://ir.uz.ac.zw/jspui/bitstream/10646/1105/1/Viol_thesis.pdf</mixed-citation></ref><ref id="scirp.69634-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Betancur-Galvis, L.A., Morales, G.E., Forero, J.E. and Roldan, J. (2002) Cytotoxic and Antiviral Activities of Colombian Medicinal Plant Extracts of the Euphorbia Genus. Memorial Institute Oswaldo Cruz, 97, 541-546.  
http://dx.doi.org/10.1590/s0074-02762002000400017</mixed-citation></ref><ref id="scirp.69634-ref14"><label>14</label><mixed-citation publication-type="book" xlink:type="simple">McLaughlin, J.L., Chang, C.J. and Smith, D.L. (1991) Bench-Top Bioassays for the Discovery of Bioactive Natural Products: An Update. In: Rhaman, A.U., Ed., Studies in Natural Products Chemistry, Elsevier, Amsterdam, 383-409.</mixed-citation></ref><ref id="scirp.69634-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Krishnaraju, A.V., Tayi Rao, V.N., Sundararaju, D., Vanisree, M., Tsay, H.S. and Subbaraju, G.V. (2006) Biological Screening of Medicinal Plants Collected from Eastern Ghats of India Using Artemiasalina (Brine Shrimp Test). International Journal of Applied Science and Engineering, 2, 115-125.</mixed-citation></ref><ref id="scirp.69634-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Reed, L.J. and Muench, H. (1938) A Simple Method of Estimating Fifty Percent Endpoints. American Journal of Hygiene, 27, 493-497.</mixed-citation></ref><ref id="scirp.69634-ref17"><label>17</label><mixed-citation publication-type="book" xlink:type="simple">Villegas, P. and Purchase, H.G. (1983) Titration of Biological Suspensions. In: Hitchner, S.B., Domermuth, C.H., Purchase, H.G. and Williams, J.E., Eds., Isolation and Identification of Avian Pathogens, 2nd Edition, The American Association of Avian Pathologists, 124-128.</mixed-citation></ref><ref id="scirp.69634-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Vlietinck, A.J., van Hoof, L., Totte, J., Lasure, A., van den Berghe, D., Rwangabo, P.C. and Mvukiyumwami, J. (1995) Screening of Hundred Rwandese Medicinal Plants for Antimicrobial and Antiviral Properties. Journal of Ethnopharmacology, 46, 31-47. http://dx.doi.org/10.1016/0378-8741(95)01226-4</mixed-citation></ref><ref id="scirp.69634-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Mongalo, N.I. and Mafoko, B.J. (2013) Cassia abbreviate Oliv. A Review of Its Ethnomedicinal Uses, Toxicology, Phytochemistry, Possible Propagation Techniques and Pharmacology. African Journal of Pharmacy and Pharmacology, 7, 2901-2906. http://dx.doi.org/10.5897/AJPP12.1017</mixed-citation></ref><ref id="scirp.69634-ref20"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gadir</surname><given-names> S.A. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>Assessment of Bioactivity of Some Sudanese Medicinal Plants Using Brine Shrimp (Artemisia salina) Lethality Assay</article-title><source> Journal of Chemical and Pharmaceutical Research</source><volume> 4</volume>,<fpage> 5145</fpage>-<lpage>5148</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.69634-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Maregesi, S.M., Pieters, L., Ngassapa, O.D., Apers, S., Vingerhoets, R., Cos, P., Vanden Berge, D.A. and Vlietinck, A.J. (2008) Screening of Some Tanzanian Medicinal Plants from Bunda District for Antibacterial, Antifungal and Antiviral Activities. Journal of Ethnopharmacology, 119, 58-66. http://dx.doi.org/10.1016/j.jep.2008.05.033</mixed-citation></ref><ref id="scirp.69634-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Moshi, M.J., Mbwambo, Z.H., Kapingu, M.C., Mhozya, V.H. and Marwa, C. (2006) Antimicrobial and Brine Shrimp Lethality of Extracts of Terminalia mollis Laws. African Journal of Traditional Complementary and Alternative Medicines, 3, 59-69. http://dx.doi.org/10.4314/ajtcam.v3i3.31166</mixed-citation></ref><ref id="scirp.69634-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Mathabe, M.C., Nikolova, R.V., Lall, H. and Nyazema, N.Z. (2006) Antibacterial Activities of Medicinal Plants Used for the Treatment of Diarrhoea in Limpopo Province, South Africa. Journal of Ethnopharmacology, 105, 286-293.  
http://dx.doi.org/10.1016/j.jep.2006.01.029</mixed-citation></ref><ref id="scirp.69634-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Drewes, S.E., Elliot, E., Khan, F., Dlamini, J.T.B. and Gcumisa, M.S.S. (2008) Hypoxis hemerocallidea—Not Merely a Cure for Benign Prostate Hyperplasia. Journal of Ethnopharmacology, 119, 593-598.  
http://dx.doi.org/10.1016/j.jep.2008.05.027</mixed-citation></ref><ref id="scirp.69634-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ncube, B., Ndlala, A.R., Okem, A. and van Staden, J. (2013) Hypoxis (Hypoxidaceae) in African Traditional Medicine. Journal of Ethnopharmacology, 150, 818-827. http://dx.doi.org/10.1016/j.jep.2013.10.032</mixed-citation></ref><ref id="scirp.69634-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Amusan, O.O.G., Sukati, N.A., Dlamini, P.S. and Sibandze, F.G. (2007) Some Swazi Phytomedicines and Their Constituents. African Journal of Biotechnology, 6, 267-272.</mixed-citation></ref><ref id="scirp.69634-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Arkhipov, A., Sirdaarta, J., Raya, P., McDonnell, P.A. and Cook, I.E. (2014) An Examination of the Antibacterial, Antifungal, Anti-Gardial and Anticancer Properties of Kigelia africana Fruit Extracts. Pharmacognosy Communications, 4, 62-76. http://dx.doi.org/10.5530/pc.2014.3.7</mixed-citation></ref><ref id="scirp.69634-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Neondo, J.O., Mbithe, C.M., Njenga, P.K. and Muthuri, W. (2012) Phytochemical Characterisation, Antibacterial Screening and Toxicity Evaluation of Dichrostachys cinerea. International Journal of Medicinal Plant Research, 1, 32-37.</mixed-citation></ref><ref id="scirp.69634-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Bessong, P.O., Obi, C.L., Igumbor, E., Andreola, M.L. and Litvak, S. (2004) In Vitro Activity of Three Selected South African Medicinal Plants against HIV Type 1 Reverse Transcriptase. African Journal of Biotechnology, 3, 555-559.  
http://dx.doi.org/10.5897/AJB2004.000-2109</mixed-citation></ref><ref id="scirp.69634-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Bessong, P.O., Obi, C.L., Andreola, M.L., Rojas, L.B., Pouysegu, L., Igumbor, E., Meyer, J.J.M., Quideau, S. and Litvak, S. (2005) Evaluation of Selected South African Medicinal Plants for Inhibitory Properties against Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Integrase. Journal of Ethnopharmacology, 99, 83-91.  
http://dx.doi.org/10.1016/j.jep.2005.01.056</mixed-citation></ref><ref id="scirp.69634-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Müller, V., Chavez, H., Reginatto, F.H., Zucolotto, S.M., Niero, R., Navarro, D., Yunes, R.A., Schenkel, E.P., Barardi, C.R.M., Zanetti, C.R. and Simoes, C.M.O. (2007) Evaluation of Antiviral Activity of South American Plant Extracts against Herpes Simplex Virus Type 1 and Rabies Virus. Phytotherapy Research, 21, 970-974.</mixed-citation></ref><ref id="scirp.69634-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Rajhandari, M., Mentel, R., Jha, P.K., Chaudhary, R.P., Bhattarai, S., Gevali, M.B., Karmachya, N., Hipper, M. and Lindequist, U. (2007) Antiviral Activity of Some Plants Used in Nepalese Traditional Medicine. Evidence Based Complementary and Alternative Medicine, 6, 517-522.</mixed-citation></ref><ref id="scirp.69634-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Abad, M.J., Guerra, J.A., Bermejo, P., Irurzun, A. and Carrasco, L. (2000) Search for Antiviral Activity in Higher Plants. Phytotherapy Research, 14, 604-667.  
http://dx.doi.org/10.1002/1099-1573(200012)14:8&lt;604::AID-PTR678&gt;3.0.CO;2-L</mixed-citation></ref><ref id="scirp.69634-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Verma, H., Patil, P.R., Kolhapure, R.M. and Gopalkrishna, V. (2008) Antiviral Activity of the Indian Medicinal Plant Extract, Swertia chirata against Herpes Simplex Viruses: A Study by in Vitro and Molecular Approach. Indiana Journal of Medical Microbiology, 26, 322-326. http://dx.doi.org/10.4103/0255-0857.43561</mixed-citation></ref><ref id="scirp.69634-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Spindola, K.C.W., Simas, N.K., Salles, T.S., Meneses, M.D.F., Sato, A., Ferreira, D., Romao, W. and Kuster, R.M. (2014) Anti-Mayaro Virus Activity of Cassia australis Extracts (Fabaceae, Leguminosa). Parasites &amp; Vectors, 7, 537.  
http://dx.doi.org/10.1186/s13071-014-0537-z</mixed-citation></ref><ref id="scirp.69634-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Nandi, C.S., Sharon, A., Sarkar, M.C., Chakabarti, S. and Chattopadhyay, D. (2013) An Indole Alkaloid from Tribal Folklore Inhibits Immediate Early Event in HSV-2 Infected Cells with Therapeutic Efficacy in Vaginally Infected Mice. PLoS ONE, 8, e77937. http://dx.doi.org/10.1371/journal.pone.0077937</mixed-citation></ref><ref id="scirp.69634-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Tang, L.I.C., Ling, A.P.K., Koh, R.Y., Chye, S.M. and Voon, K.G.L. (2012) Screening of Anti-Dengue Activity in Methanolic Extracts of Medicinal Plants. BMC Complementary and Alternative Medicine, 12, 3.  
http://dx.doi.org/10.1186/1472-6882-12-3</mixed-citation></ref><ref id="scirp.69634-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Swain, S.S. and Dubey, J. (2013) Anti-Dengue Medicinal Plants: A Mini-Review. Research and Reviews: Journal of Pharmacognosy and Phytochemistry, 1, 5-9.</mixed-citation></ref><ref id="scirp.69634-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">De Ridder, S., van der Kooy, F. and Verpoorte, R. (2008) Artemisia annua as Self Reliant Treatment in Developing Countries. Journal of Ethnopharmacology, 120, 302-314. http://dx.doi.org/10.1016/j.jep.2008.09.017</mixed-citation></ref></ref-list></back></article>